Author

Doha Al Krad

Universitätsmedizin Göttingen

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:multiple species· 1 Assay:proteomics· 1

Frequent Co-Authors

Angele BreithauptiD· 1 shared Anne Balkema‐BuschmanniD· 1 shared Antje DickmannsiD· 1 shared Björn-Patrick Mohl· 1 shared Claudia Blaurock· 1 shared Kim M. StegmanniD· 1 shared Matthias DobbelsteiniD· 1 shared Priya KumariD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Angele BreithauptORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

The protease inhibitor Nirmatrelvir synergizes with inhibitors of GRP78 to suppress SARS-CoV-2 replication

Doha Al Krad, Kim M. Stegmann, Antje Dickmanns, Priya Kumar, Claudia Blaurock, Björn-Patrick Mohl, Sina Jasmin Wille, Angele Breithaupt, Tobias Britzke, Anne Balkema‐Buschmann, Matthias Dobbelstein

This study shows that combining Nirmatrelvir with GRP78 inhibitors strongly reduces SARS-CoV-2 replication in vitro and in a hamster model.

Antiviral Research · Jul 29, 2025Peer-reviewedMicrobiology